Sales Revenue in the Osmolarity Testing Device Market to Witness Growth at Robust CAGR XX% During 2018 - 2026

07/apr/2020 12:47:43 persistencemarketresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Osmolarity and osmolality are the units of measurement of solute concentration in a solution. Both the techniques are nowadays extensively used for the accurate diagnosis of diseases associated with body fluids. An osmolarity testing device is used to test a variety of solutions such as blood, plasma, urine, serum, cell culture media and others.

Osmolarity measurement is considered as an important tool in diagnostic applications. Osmolarity testing of tears is nowadays considered as the gold standard test for the diagnosis of dry eye syndrome, whereas osmolality of blood and urine determines the salt-to-water balance and the renal function of body.

These two parameters provide information about several clinical disorders such as electrolyte disturbances, exogenous intoxication and hydration status, owing to the fact that these solute concentrations controls the body fluid movement between intravascular and interstitial spaces of body tissues.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @

Osmolarity and osmolality testing are used to investigate low sodium levels in the blood (hyponatremia), increased or decreased urine production, alcohol poisoning due to ingestion of toxins and to help determine the cause of chronic diarrhea.

Osmolarity testing devices available in the market are based on techniques such as freezing point depression, vapour pressure and electrical impedance. Each technology has its merits and demerits, varying from time consumed, complexity and results. The freezing point depression method is the oldest method of diagnosis, in which the sample is supercooled to its freezing point.

Osmolarity Testing Device Market: Drivers & Restraints

The increasing trend of miniaturization and development of advanced instruments producing reproducible, accurate and reliable results are fuelling the osmolarity testing devices market as these advanced device enhance the clinician’s ability to diagnose diseases.

In addition to this, increasing awareness, rising healthcare expenditure, growing geriatric population, and improvement in pathological services are also expected to contribute to the growth of the osmolarity testing devices market. Lack of skilled professionals in under-developed and developing countries and the presence of limited market players limit the growth of the osmolarity testing devices market.

Access Full TOC of This Report @

Osmolarity Testing Device Market: Segmentation

By Technology Type:

  • Freezing Point Depression
  • Vapor Pressure
  • Electrical Impedance

By Product Type:

  • Table-top Devices
  • Handheld Devices

By Sample Type:

  • Blood
  • Urine
  • Tears
  • Other Fluids

By End Users

  • Hospitals
  • Ophthalmology & Optometry Clinics
  • Pathology Laboratories
  • Research Laboratories

Newer osmolarity testing devices are being developed to increase simplicity, convenience and accuracy for the routine diagnosis as well as to reduce the sample volume and time taken.

There is an opportunity for market players to develop low cost and economical devices while improving laboratory efficiency and throughput. There is also a growing trend in point of care devices for clinical diagnosis using the electrical impedance technique to measure osmolarity.

For In-Depth Competitive Analysis, Buy Now @

More About the Report –

Unprecedented access to a world of information has given rise to the empowered, albeit distrustful, consumer. So is the case with healthcare, where the patient has been rendered more informed and conscientious thanks to the extraordinary penetration of the Internet. The discerning patient now demands more affordable, sophisticated, transparent, and personalized healthcare services, creating the need for new models for care.

The advent of health information technology (HIT) components such as electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and vendor-neutral archives (VNA) has had just as transformational an impact on the overall healthcare sector as the concerns regarding security and privacy. Data theft, undue access to personal health records, and cyber-attacks are very real threats that the healthcare sector faces today.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

Molecular Diagnostics Market –

Molecular Diagnostics Market Segmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.

Next-Generation Sequencing Market – 

Next Generation Sequencing Market Segmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.

Ophthalmology devises Market –

Ophthalmology devises Market Segmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.

Intravenous Iron Drugs Market – 

Intravenous (IV) Iron Drugs Market Segmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., and Sanofi.

Syndromes Progressive Ataxia Weakness Disorders Market – 

Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Market Segmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States +1-646-568-7751
E-mail id-

blog comments powered by Disqus è un servizio offerto da Factotum Srl